Steven Cohen's PROK Position Overview
Steven Cohen (via Point72 Asset Management, L.P.) currently holds 65,578 shares of ProKidney Corp. (PROK) worth $117,385, representing 0.00% of the portfolio. First purchased in 2025-Q4, this recently established position has been held for 2 quarters.
Based on recent 13F filings, Steven Cohen has initiated a new position in PROK, representing a fresh investment thesis on this company. Largest addition occurred in Q1 2026, adding 48,491 shares.
Analysis based on 13F filings available since 2013 Q2
Steven Cohen's ProKidney (PROK) Holding Value Over Time
Track share changes against reported price movement
Quarterly ProKidney (PROK) Trades by Steven Cohen
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +48,491 | Add 283.79% | 65,578 | $1.79 |
| Q4 2025 | +17,087 | New Buy | 17,087 | $2.24 |
Steven Cohen's ProKidney Investment FAQs
Steven Cohen first purchased ProKidney Corp. (PROK) in Q4 2025, acquiring 17,087 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Steven Cohen has held ProKidney Corp. (PROK) for 2 quarters since Q4 2025.
Steven Cohen's largest addition to ProKidney Corp. (PROK) was in Q1 2026, adding 65,578 shares worth $117,385.
According to the latest 13F filing for Q1 2026, Steven Cohen's firm, Point72 Asset Management, L.P., owns 65,578 shares of ProKidney Corp. (PROK), valued at approximately $117,385.
As of the Q1 2026 filing, ProKidney Corp. (PROK) represents approximately 0.00% of Steven Cohen's publicly disclosed stock portfolio, making it one of their key holdings.
Steven Cohen's peak holding in ProKidney Corp. (PROK) was 65,578 shares, as reported at the end of Q1 2026.